Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Japanese researchers present radiation-induced injury treatments

June 27, 2014

Orexo reports phase III data on Zubsolv for induction of buprenorphine maintenance therapy

June 25, 2014

Bunavail buccal film approved by FDA for opioid dependence

June 11, 2014

Pfizer researchers design nicotine vaccines with higher avidity

May 26, 2014

Double-blind trial finds (S)-(-)-OSU-6162 effective in treating alcohol dependence

May 9, 2014

FDA approves Evzio for the emergency treatment of opioid overdose

April 7, 2014

Medesis Pharma and CEA sign collaborative agreement

April 3, 2014

Southwest Research Institute receives contract extension for cyanide antidote

March 31, 2014

New monoclonal antibodies for the treatment of botulism disclosed

March 24, 2014

MediciNova announces start of MN-166 clinical study for marijuana dependence

March 11, 2014

Popular Stories

Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
Innervation can slow, as well as speed, tumor growth, study finds
BioWorld
Innervation by the sympathetic nervous system is typically a boon to tumors. But researchers from Weill Cornell Medicine and colleagues have shown that in some...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.